MUC5B Expression Is Associated with Reduced Respiratory Syncytial Virus Infection and Pulmonary Inflammation

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease, particularly in infants and older adults. During RSV infection, excessive secretion and accumulation of gel-forming mucins can obstruct the small airways and contribute to pulmonary pathology. However, airway mucins also form a first-line barrier that traps inhaled pathogens and limits their access to the airway epithelium. Whether MUC5B, a major secreted mucin in the lower respiratory tract, influences RSV infection and associated pulmonary responses remains poorly understood. Here, we investigated the role of MUC5B during RSV infection using human A549 epithelial cells stably overexpressing MUC5B and female Muc5b-deficient mice. MUC5B overexpression significantly reduced intracellular RSV RNA levels following infection with the A2, Long, and B1 strains. In vivo, Muc5b−/− mice exhibited substantially higher pulmonary RSV RNA burdens at 5 days post-infection, whereas no significant genotype-dependent differences were detected in the nasal turbinates. Muc5b deficiency was also associated with more severe respiratory tract pathology and a higher proportion of pulmonary neutrophils after RSV infection. Eosinophil proportions increased after infection in both wild-type and Muc5b−/− mice, whereas the proportions of alveolar macrophages decreased and those of interstitial macrophages increased in both genotypes. Collectively, these findings suggest that, despite the established contribution of excessive mucus accumulation to airway obstruction, MUC5B also has a protective role during RSV infection. MUC5B may enhance pulmonary resistance to RSV by contributing to airway barrier function, reducing pulmonary viral burden, limiting tissue injury, and attenuating neutrophilic inflammation. These findings identify MUC5B as an important component of mucosal antiviral defense and broaden our understanding of how airway mucins influence susceptibility to RSV infection.

Authors

Institutions

Publication Details

Journal
Pathogens
Published
2026-10-26
DOI
https://doi.org/10.3390/pathogens15111120
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MUC5B Expression Is Associated with Reduced Respiratory Syncytial Virus Infection and Pulmonary Inflammation

Su Zhang, Changgui Li, Jiaojiao Nie, Yaru Quan et al.
Pathogens
Respiratory viral infections research
article

MUC5B Expression Is Associated with Reduced Respiratory Syncytial Virus Infection and Pulmonary Inflammation

Su Zhang, Changgui Li, Jiaojiao Nie, Yaru Quan, Wenwen Wang, Yufang Sun, Huijie Yang, Lian Liu, Ying Xie
article en

Abstract

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease, particularly in infants and older adults. During RSV infection, excessive secretion and accumulation of gel-forming mucins can obstruct the small airways and contribute to pulmonary pathology. However, airway mucins also form a first-line barrier that traps inhaled pathogens and limits their access to the airway epithelium. Whether MUC5B, a major secreted mucin in the lower respiratory tract, influences RSV infection and associated pulmonary responses remains poorly understood. Here, we investigated the role of MUC5B during RSV infection using human A549 epithelial cells stably overexpressing MUC5B and female Muc5b-deficient mice. MUC5B overexpression significantly reduced intracellular RSV RNA levels following infection with the A2, Long, and B1 strains. In vivo, Muc5b−/− mice exhibited substantially higher pulmonary RSV RNA burdens at 5 days post-infection, whereas no significant genotype-dependent differences were detected in the nasal turbinates. Muc5b deficiency was also associated with more severe respiratory tract pathology and a higher proportion of pulmonary neutrophils after RSV infection. Eosinophil proportions increased after infection in both wild-type and Muc5b−/− mice, whereas the proportions of alveolar macrophages decreased and those of interstitial macrophages increased in both genotypes. Collectively, these findings suggest that, despite the established contribution of excessive mucus accumulation to airway obstruction, MUC5B also has a protective role during RSV infection. MUC5B may enhance pulmonary resistance to RSV by contributing to airway barrier function, reducing pulmonary viral burden, limiting tissue injury, and attenuating neutrophilic inflammation. These findings identify MUC5B as an important component of mucosal antiviral defense and broaden our understanding of how airway mucins influence susceptibility to RSV infection.

PathogensVol. 15(11)
Chinese Academy of Sciences (CN), Institute of Biophysics (CN), National Institutes for Food and Drug Control (CN)
National Science and Technology Major Project
Openalex Percentile: Top 12%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon